Precose (acarbose) decreases the risk of hypertension and heart disease in PRE-diabetes patients

New evidence suggests that Precose (acarbose) decreases the risk of hypertension and heart disease in PRE-diabetes patients.

Many of these patients develop type 2 diabetes...and can have up to a 10 times higher risk of heart disease-related death.

Pre-diabetes patients who take Precose over 3 years have a lower risk of developing diabetes...hypertension...and heart disease.

Upgrade now to access this resource

This content is not available under the subscriptions purchased by your organization, but you can add it on!

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.